Molina director receives 237-share stock grant

ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Ronna Romney received a stock grant through her revocable trust as part of routine board compensation. The trust was awarded 237 shares of common stock under the 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.

This quarterly grant represents an equity value of $55,000, one quarter of a $220,000 annual equity award for directors. Following this award, the Ronna Romney Revocable Trust holds a total of 17,869 Molina Healthcare shares, reflecting ongoing compensation rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 1 txn

Insider ROMNEY RONNA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 17,869 shares (Indirect, Held by trust)

Footnotes (4)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.
4. F4. All shares held by Ronna Romney Revocable Trust.

Key Figures

Shares granted: 237 shares Grant price: $232.55 per share Quarterly equity value: $55,000 +2 more

5 metrics

Shares granted 237 shares Quarterly director equity grant on July 1, 2026

Grant price $232.55 per share Closing price of common stock on July 1, 2026

Quarterly equity value $55,000 One quarter of directors’ $220,000 annual equity award

Annual equity award $220,000 Aggregate dollar value of each director’s annual equity compensation

Post-grant holdings 17,869 shares Total Molina Healthcare shares held by Ronna Romney Revocable Trust after grant

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price, revocable trust

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter"

closing price financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares."

revocable trust financial

"All shares held by Ronna Romney Revocable Trust."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Ronna Romney report in this Form 4 filing?

Ronna Romney reported receiving 237 shares of Molina Healthcare common stock via her revocable trust. The shares were granted as part of her director compensation under the 2025 Equity Incentive Plan, rather than purchased on the open market.

How was the Molina Healthcare (MOH) director stock grant to Ronna Romney valued?

The quarterly equity grant to Ronna Romney was valued at $55,000. This amount was determined using Molina Healthcare’s July 1, 2026 closing stock price of $232.55 per share, resulting in an award of 237 shares to her revocable trust.

What is the total annual equity award for Molina Healthcare (MOH) directors?

Each Molina Healthcare director has an annual equity award targeted at $220,000. This is structured as four quarterly grants of $55,000 each, with the number of shares determined using the company’s closing stock price on the first day of each quarter.

How many Molina Healthcare (MOH) shares does Ronna Romney’s trust hold after this transaction?

After the July 1, 2026 equity grant, the Ronna Romney Revocable Trust holds 17,869 shares of Molina Healthcare common stock. This total reflects shares held indirectly through the trust, including the newly granted 237-share quarterly award.

Was the Molina Healthcare (MOH) director transaction a market buy or sell of shares?

The transaction was not a market buy or sell. It was a grant of 237 shares to Ronna Romney’s revocable trust under Molina Healthcare’s 2025 Equity Incentive Plan, representing routine stock-based compensation for her service as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROMNEY RONNA

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	17,869	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

4. All shares held by Ronna Romney Revocable Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Ronna Romney.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)